Home> Products> excellent adjunct

{ "products": [ { "_id": "6960c83f3056ad8a5a1aecba", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinnarizine and Domperidone Tablets ", "description": "CLANARIZINE DOM represents an advanced pharmaceutical combination that brings together two potent therapeutic agents—Cinnarizine and Domperidone—in a single convenient tablet formulation. This innovative combination medication addresses multiple aspects of vestibular disorders, motion sickness, and associated nausea and vomiting, providing comprehensive relief for patients suffering from these debilitating conditions. Manufactured under stringent quality control standards, CLANARIZINE DOM offers a synergistic approach to managing symptoms that significantly impact quality of life and daily functioning.The combination of Cinnarizine and Domperidone in CLANARIZINE DOM is based on sound pharmacological principles. While Cinnarizine works primarily on the vestibular system to reduce dizziness and vertigo, Domperidone acts as an effective antiemetic to control nausea and vomiting. Together, these two active ingredients provide more comprehensive symptom control than either agent alone, making CLANARIZINE DOM an excellent choice for patients experiencing vestibular disturbances accompanied by gastrointestinal symptoms.This combination therapy is particularly valuable because vertigo, dizziness, and motion sickness are frequently accompanied by nausea and vomiting. Patients suffering from these conditions often find that addressing only one aspect of their symptoms provides insufficient relief. CLANARIZINE DOM's dual-action formula tackles both the underlying vestibular dysfunction and the accompanying gastrointestinal distress, offering patients a more complete therapeutic solution that improves both comfort and functional capacity.Understanding the Active IngredientsCinnarizine is a calcium channel blocker with specific antihistaminic and vestibular suppressant properties. Unlike systemic calcium channel blockers used for cardiovascular conditions, Cinnarizine selectively acts on the blood vessels in the inner ear and brain, improving blood flow to these areas. This enhanced circulation helps reduce the frequency and severity of vertigo attacks while also preventing motion sickness. Cinnarizine also possesses mild antihistaminic effects that contribute to its anti-nausea properties, though this is not its primary mechanism of action.The medication works by blocking calcium channels in the vestibular system, which helps stabilize the sensory organs responsible for balance. By reducing the excessive stimulation of the vestibular apparatus, Cinnarizine decreases the sensation of spinning or imbalance that characterizes vertigo. Additionally, its vasodilatory effects improve microcirculation in the inner ear, which can be beneficial for conditions where reduced blood flow contributes to symptoms.Domperidone is a peripheral dopamine antagonist that acts primarily as a prokinetic and antiemetic agent. Unlike some antiemetic medications that cross the blood-brain barrier and cause sedation or extrapyramidal side effects, Domperidone works predominantly in the peripheral nervous system. It blocks dopamine receptors in the chemoreceptor trigger zone (CTZ) located outside the blood-brain barrier, effectively preventing nausea and vomiting without causing significant central nervous system effects.Domperidone also enhances gastrointestinal motility by promoting coordinated contractions of the stomach and upper small intestine. This prokinetic effect helps empty the stomach more efficiently, reducing feelings of fullness, bloating, and discomfort that often accompany vestibular disorders. By accelerating gastric emptying, Domperidone also reduces the likelihood of gastroesophageal reflux, which can exacerbate nausea in some patients.The combination of these two medications in CLANARIZINE DOM creates a complementary therapeutic effect. While Cinnarizine addresses the vestibular component of dizziness and vertigo, Domperidone manages the gastrointestinal symptoms that frequently accompany these conditions. This dual approach provides more comprehensive symptom relief and improves overall treatment outcomes compared to monotherapy with either agent alone.Clinical Applications and UsesCLANARIZINE DOM is indicated for a wide range of conditions characterized by vertigo, dizziness, and associated nausea. Understanding these clinical applications helps healthcare providers select appropriate candidates for this combination therapy.Vestibular Disorders: The primary indication for CLANARIZINE DOM includes various vestibular disorders that cause vertigo and imbalance. These conditions include Ménière's disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis. Patients with these disorders experience episodes of spinning sensation, loss of balance, and often severe nausea. CLANARIZINE DOM helps reduce the frequency and intensity of vertigo attacks while controlling the accompanying gastrointestinal symptoms.Motion Sickness: CLANARIZINE DOM is highly effective for preventing and treating motion sickness, whether related to travel by car, boat, airplane, or amusement park rides. The medication can be taken prophylactically before travel or at the onset of symptoms. The combination is particularly useful for individuals who experience severe nausea and vomiting with motion sickness, as Domperidone provides powerful antiemetic effects that complement Cinnarizine's anti-motion-sickness properties.Migraine-Associated Vertigo: Many patients with migraines experience vestibular symptoms, including dizziness, vertigo, and motion sensitivity, either during migraine attacks or as independent episodes. CLANARIZINE DOM can help manage these vestibular manifestations of migraine, reducing both the vertigo and the nausea that often accompany migraine headaches.Post-Concussion Syndrome: Following head injuries, some patients develop persistent dizziness, balance problems, and nausea as part of post-concussion syndrome. CLANARIZINE DOM may provide symptomatic relief for these patients during their recovery period, though it should be used as part of a comprehensive treatment approach that includes rest, gradual return to activities, and vestibular rehabilitation when appropriate.Cerebrovascular Insufficiency: In older adults with reduced blood flow to the brain, symptoms such as dizziness, vertigo, tinnitus (ringing in the ears), and cognitive difficulties may develop. Cinnarizine's vasodilatory properties can improve cerebral circulation, potentially reducing these symptoms. The addition of Domperidone helps manage any associated nausea.Radiation-Induced or Chemotherapy-Induced Nausea: While not a primary indication, some healthcare providers use CLANARIZINE DOM as adjunctive therapy for patients undergoing cancer treatment who experience both nausea and dizziness. Domperidone's strong antiemetic properties are particularly valuable in this context.Key Benefits of CLANARIZINE DOMThe unique combination of Cinnarizine and Domperidone in CLANARIZINE DOM offers numerous advantages that make it a preferred choice for managing vestibular disorders and associated symptoms.Comprehensive Symptom Control: The primary benefit of CLANARIZINE DOM is its ability to address multiple symptoms simultaneously. Rather than requiring patients to take separate medications for vertigo and nausea, this combination provides unified treatment in a single tablet. This comprehensive approach improves symptom control across the full spectrum of vestibular disorder manifestations, from the spinning sensation to the gastrointestinal distress that often accompanies it.Improved Patient Compliance: Taking multiple medications can be burdensome, particularly for patients who feel dizzy or nauseated. CLANARIZINE DOM simplifies the treatment regimen by combining two medications in one tablet, making it easier for patients to adhere to their prescribed therapy. Better compliance translates to better outcomes, as consistent medication use is essential for managing chronic vestibular conditions.Synergistic Therapeutic Effects: The combination of Cinnarizine and Domperidone creates synergistic effects that enhance overall efficacy. While Cinnarizine reduces vestibular stimulation and improves inner ear blood flow, Domperidone prevents nausea and promotes gastric emptying. This dual action addresses both the cause and consequences of vestibular dysfunction, providing more complete relief than either medication alone.Reduced Central Nervous System Side Effects: Because Domperidone works primarily in the peripheral nervous system rather than crossing the blood-brain barrier extensively, CLANARIZINE DOM causes less sedation and fewer cognitive effects compared to some alternative antiemetic medications. This allows patients to maintain better alertness and function during treatment, which is particularly important for those who need to continue working or performing daily activities.Enhanced Quality of Life: Vertigo and chronic dizziness significantly impair quality of life, limiting mobility, social interactions, and occupational functioning. The nausea and vomiting that accompany these conditions add another layer of disability. By effectively controlling both vestibular and gastrointestinal symptoms, CLANARIZINE DOM helps restore patients' ability to engage in normal activities, improving overall life satisfaction and functional independence.Fast Onset of Action: CLANARIZINE DOM provides relatively rapid symptom relief, with many patients experiencing improvement within 30 minutes to 2 hours after taking the medication. This quick onset is particularly valuable for acute episodes of vertigo or when taking the medication prophylactically before situations that might trigger motion sickness.Suitable for Long-Term Use: For patients with chronic vestibular disorders requiring ongoing treatment, CLANARIZINE DOM is generally safe for extended use when properly monitored by a healthcare provider. The medication maintains its effectiveness over time without significant tolerance development, making it suitable for long-term symptom management.Improved Gastric Emptying: The prokinetic effects of Domperidone benefit not only nausea but also other gastrointestinal symptoms such as early satiety, bloating, and upper abdominal discomfort. Patients with vestibular disorders often develop gastroparesis or delayed gastric emptying secondary to their condition, and Domperidone addresses this issue effectively.Vascular Benefits: Cinnarizine's ability to improve blood flow to the inner ear and brain provides additional benefits beyond symptom control. Enhanced microcirculation may support healing and recovery in conditions where vascular insufficiency contributes to vestibular dysfunction.Side Effects and Safety ConsiderationsLike all medications, CLANARIZINE DOM can cause side effects, though not everyone experiences them. Understanding potential adverse effects helps patients recognize when to seek medical attention and allows healthcare providers to monitor therapy appropriately.Common Side Effects:The most frequently reported side effect of CLANARIZINE DOM is drowsiness or sedation, occurring in approximately 10-20% of patients. This effect is primarily attributable to Cinnarizine's antihistaminic properties. Patients should avoid driving or operating machinery until they know how the medication affects them. Taking the medication at bedtime can minimize daytime drowsiness for some patients.Dry mouth is another common side effect, affecting roughly 10-15% of patients. This occurs due to anticholinergic effects and can be managed by sipping water frequently, chewing sugar-free gum, or using saliva substitutes if severe. Maintaining good oral hygiene is important to prevent dental problems associated with reduced saliva production.Mild gastrointestinal symptoms, including constipation, abdominal discomfort, or changes in bowel habits, may occur. While Domperidone promotes gastric emptying, it can occasionally alter bowel motility. These effects are usually mild and resolve with continued use or dose adjustment.", "price": 55.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2271, "imageuri": "https://productimages.withfloats.com/actual/6960c8410b0da405bc908e58.png", "tileimageuri": "https://productimages.withfloats.com/tile/6960c8410b0da405bc908e58.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-09T09:19:59.281Z", "updatedon": "2026-03-12T09:24:10.244Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cinnarizine-and-domperidone-tablets-/2271", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CLANARIZINE DOM", "category": "NEUROLOGY RANGE", "tags": [ "cinnarizine and domperidone tablet uses", "what is cinnarizine & domperidone tablet used for", "cinnarizine domperidone combination medicine benefits", "how cinnarizine domperidone tablet works", "cinnarizine domperidone tablet for vertigo treatment", "cinnarizine domperidone tablet for inner ear problem", "cinnarizine domperidone tablet for balance disorder", "cinnarizine domperidone tablet for travel sickness", "cinnarizine domperidone tablet for gastric nausea", "cinnarizine & domperidone tablet price in india", "cinnarizine domperidone tablet brand name", "cinnarizine domperidone tablet manufacturer in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69143c14e91a8f3f57dea824", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rifaximin oral suspension 100mg/5ml", "description": "Rifaximin Oral Suspension 100 mg/5 ml is a broad-spectrum, gut-selective antibiotic formulated to treat various bacterial infections of the gastrointestinal tract, including traveler’s diarrhea, hepatic encephalopathy-related symptoms, and irritable bowel syndrome with diarrhea (IBS-D). Its unique non-systemic activity ensures that the drug acts locally in the intestines without significant absorption into the bloodstream, making it both effective and safe for long-term gastrointestinal management.\n\nDesigned in a pleasant-tasting, easy-to-administer oral suspension form, Rifaximin 100 mg/5 ml is especially suitable for pediatric patients and adults who have difficulty swallowing tablets. It is ideal for treating infections caused by non-invasive strains of Escherichia coli and other enteric bacteria, while also helping maintain intestinal balance and promoting recovery from gut-related complications.\nComposition\nEach 5 ml of suspension contains:\n\nRifaximin IP – 100 mg\n\nFlavored base and excipients – q.s.\n\nDosage Form: Oral Suspension\nAppearance: Pink to reddish suspension (depending on brand formulation)\nPackaging: Available in 30 ml, 60 ml, or 100 ml bottles with a measuring cup for accurate dosing.\n\nPharmacological Action and Mechanism\nRifaximin belongs to the rifamycin class of antibiotics and is structurally related to rifampicin. However, it has been specially modified to act locally in the gastrointestinal tract with negligible systemic absorption (<0.4%).\nMechanism of Action:\nRifaximin inhibits bacterial RNA synthesis by binding to the β-subunit of the bacterial DNA-dependent RNA polymerase.\nThis action prevents the transcription process, thereby stopping bacterial growth and replication.\nIts broad-spectrum activity covers both gram-positive and gram-negative bacteria, including aerobic and anaerobic strains.\nDue to poor absorption, it remains in the intestine at high concentrations, providing localized antibacterial effect without systemic toxicity.\n\nAdditionally, Rifaximin exerts eubiotic effects — it helps restore normal intestinal flora balance by selectively targeting harmful bacteria, which makes it useful for chronic intestinal disorders.\nUses and Indications\nRifaximin Oral Suspension 100 mg/5 ml is indicated for the following conditions:\n\nTraveler’s Diarrhea (TD):\n\nCaused by non-invasive strains of Escherichia coli.\nHelps relieve symptoms like watery stools, abdominal cramps, and bloating within a short duration.\nHepatic Encephalopathy (HE):\n\nUsed as adjunct therapy to reduce ammonia-producing gut bacteria, thereby lowering blood ammonia levels and improving mental status in patients with chronic liver disease.\n\nIrritable Bowel Syndrome with Diarrhea (IBS-D):\nProvides relief from abdominal pain, bloating, and irregular bowel movements by reducing bacterial overgrowth in the small intestine (SIBO).\nSmall Intestinal Bacterial Overgrowth (SIBO):\nHelps normalize gut flora and reduces gas, bloating, and discomfort caused by bacterial overgrowth.\nGastrointestinal Infections in Children:\nEffective in pediatric patients suffering from infectious diarrhea due to bacterial contamination of food or water.\n\nProphylactic Use:\nMay be prescribed post-surgery or in chronic liver disease to prevent recurrence of infection-related complications.\nDosage and Administration\nAdults and Children (>12 years): Usual dose is 10–20 ml (200–400 mg) every 8–12 hours, depending on the indication and physician’s recommendation.\nChildren (2–12 years): 5–10 ml (100–200 mg) two or three times daily, as directed by a pediatrician.\nShake the bottle well before each use.\nComplete the prescribed course even if symptoms improve early to prevent recurrence and antibiotic resistance.\nKey Benefits\nGut-Selective Action:\nActs locally within the intestine without entering systemic circulation, ensuring targeted therapy with minimal side effects.\n\nBroad-Spectrum Antibacterial Activity:\nEffective against a wide range of gram-positive, gram-negative, aerobic, and anaerobic enteric pathogens.\nSafe for Pediatric and Adult Use:\nThe liquid form allows accurate dosing and ease of administration, especially for children or elderly patients.\n\nMinimal Systemic Absorption:\nReduces the risk of systemic toxicity and drug interactions compared to conventional antibiotics.\nEffective for Traveler’s Diarrhea:\nRapidly controls diarrhea symptoms caused by E. coli and restores normal intestinal function.\nImproves Liver Health in Hepatic Encephalopathy:\nDecreases ammonia-producing bacteria, thereby reducing confusion, lethargy, and other symptoms related to hepatic encephalopathy.\n\nRestores Gut Microbiota Balance:\nHelps maintain healthy intestinal flora, supporting digestion and preventing recurrent infections.\n\nReduces Bloating and Abdominal Discomfort in IBS-D:\nProvides symptomatic relief and enhances quality of life in patients suffering from chronic bowel irregularities.\nLow Risk of Resistance:\nDue to its minimal absorption and targeted mechanism, the development of bacterial resistance is significantly lower.\nWell-Tolerated Formulation:\nThe oral suspension is gentle on the stomach and has a pleasant taste, improving compliance in children and adults alike.\n\nPrecautions and Warnings\n\nWhile Rifaximin Oral Suspension is considered safe for most patients, the following precautions should be observed:\n\nAllergy: Avoid use in patients with known hypersensitivity to rifaximin, rifampicin, or other rifamycin derivatives.\n\nSevere Diarrhea or Bloody Stool: If symptoms worsen or persist beyond 48 hours, consult a physician; may indicate an invasive infection requiring alternative therapy.\n\nLiver Impairment: Use with caution in patients with severe hepatic impairment; dosage adjustments may be required.\n\nPregnancy and Lactation: Limited data available; should be used only if clearly needed and prescribed by a doctor.\n\nLong-Term Use: Prolonged or unnecessary use may lead to superinfection by non-susceptible organisms, including fungi.\n\nDriving and Machinery: Generally safe, but dizziness or fatigue may occur in rare cases.\n\nPossible Side Effects\n\nRifaximin is generally well-tolerated due to its localized action in the gut. However, some mild to moderate side effects may occur in sensitive individuals.\n\nCommon Side Effects:\n\nNausea\n\nFlatulence (gas)\n\nAbdominal pain or cramping\n\nHeadache\n\nBloating\n\nConstipation\n\nLess Common / Rare Side Effects:\n\nSkin rash or itching\n\nDizziness or fatigue\n\nElevated liver enzymes (rare)\n\nVomiting or dry mouth\n\nFever or flu-like symptoms\n\nSerious Side Effects (Very Rare):\n\nAllergic reaction (rash, swelling, or breathing difficulty)\n\nPersistent watery or bloody diarrhea\n\nSevere abdominal pain\n\nIf any severe adverse reactions occur, discontinue use and seek medical attention immediately.\n\nStorage and Handling\n\nStore below 30°C in a cool, dry place.\n\nProtect from direct sunlight and freezing.\n\nShake well before use.\n\nKeep out of reach of children.\n\nDiscard any unused portion after the treatment course or expiry date.\n\nConclusion\n\nRifaximin Oral Suspension 100 mg/5 ml is a clinically trusted and patient-friendly antibiotic formulation for the treatment of gastrointestinal infections and liver-related complications. Its unique non-systemic mode of action, combined with broad antibacterial efficacy, makes it an excellent choice for both acute and chronic intestinal disorders.\n\nUnlike traditional antibiotics that circulate systemically, Rifaximin works locally within the intestines to eliminate harmful bacteria while preserving the natural gut flora. This results in faster relief from symptoms like diarrhea, bloating, and abdominal discomfort — with minimal side effects.\nWhether used for traveler’s diarrhea, hepatic encephalopathy, IBS-D, or bacterial overgrowth syndromes, Rifaximin offers targeted, safe, and effective therapy for restoring digestive health and improving overall well-being.", "price": 170.0, "discountamount": 51.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2204, "imageuri": "https://productimages.withfloats.com/actual/69143c160712d1e28ab8336e.png", "tileimageuri": "https://productimages.withfloats.com/tile/69143c160712d1e28ab8336e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-12T07:49:40.243Z", "updatedon": "2026-03-12T07:37:08.06Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rifaximin-oral-suspension-100mg-5ml/2204", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RIFAXEMANIA KID", "category": "Pediatric", "tags": [ "Rifaximin Oral Suspension 100 mg/5 ml", "antibiotic", "astrointestinal management.", "Rifaximin IP – 100 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6912f583bd635de199b5deaf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gabapentin Tablets 400 mg", "description": "Gabapentin Tablets 400 mg is a widely prescribed medication belonging to the class of anticonvulsants or antiepileptic drugs. It is primarily used to treat neuropathic pain (nerve pain) and epileptic seizures. Gabapentin works by affecting chemicals and nerve signals in the brain that cause seizures or pain.\n\nEach tablet contains 400 mg of Gabapentin as the active ingredient, formulated to deliver reliable absorption and consistent therapeutic results. It helps manage chronic nerve pain resulting from conditions such as diabetic neuropathy, postherpetic neuralgia (pain following shingles), and sciatica. In addition, Gabapentin is also used as adjunctive therapy in the management of partial seizures (with or without secondary generalization) in adults and children.\n\nWith its dual role in pain control and seizure prevention, Gabapentin 400 mg offers comprehensive neurological support and enhances the quality of life for individuals suffering from long-term nerve-related conditions.\n\nUses and Therapeutic Indications\n\nGabapentin 400 mg Tablets are used to treat the following conditions:\n\nNeuropathic Pain:\nHelps relieve nerve pain caused by diabetes (diabetic neuropathy), shingles (postherpetic neuralgia), spinal cord injury, or other nerve damage.\n\nEpilepsy (Partial Seizures):\nUsed as adjunct therapy to control partial seizures with or without secondary generalization in adults and children over 12 years.\n\nFibromyalgia:\nProvides symptomatic relief from chronic musculoskeletal pain and nerve hypersensitivity.\n\nRestless Legs Syndrome (RLS):\nMay be used to reduce discomfort and restlessness in the legs, improving sleep quality.\n\nPost-Surgical Nerve Pain or Neuralgia:\nHelps reduce persistent nerve pain following surgeries or trauma.\n\nBy modulating neurotransmitter activity, Gabapentin helps restore normal nerve function and decreases abnormal excitability in the nervous system.\n\nKey Benefits\n\nEffective Relief from Nerve Pain:\nGabapentin 400 mg provides targeted relief from chronic nerve-related pain, often resistant to standard painkillers.\n\nPrevents and Controls Seizures:\nWorks as an antiepileptic drug to reduce abnormal electrical activity in the brain, preventing seizure episodes.\n\nImproves Sleep and Quality of Life:\nBy relieving persistent nerve pain, Gabapentin helps improve sleep patterns and enhances overall well-being.\n\nSuitable for Long-Term Use:\nWell-tolerated for chronic conditions requiring prolonged therapy, such as diabetic neuropathy or postherpetic neuralgia.\n\nAdjunctive Flexibility:\nCan be safely combined with other antiepileptic or pain management medications under medical supervision.\n\nReduces Dependence on Opioids:\nAn excellent non-opioid alternative for managing chronic neuropathic pain, helping reduce the risks associated with opioid use.\n\nWell-Studied and Trusted:\nBacked by extensive clinical research and years of use, Gabapentin remains one of the most prescribed and reliable treatments for neuropathic conditions.\n\nPossible Side Effects\n\nAlthough Gabapentin Tablets 400 mg are generally well tolerated, some patients may experience mild to moderate side effects, particularly at the beginning of treatment or during dose adjustments. These may include:\n\nDrowsiness or Fatigue: A common effect, especially when starting the medication.\n\nDizziness or Unsteadiness: May occur temporarily as the body adjusts.\n\nSwelling of Hands or Feet (Peripheral Edema): Usually mild and reversible.\n\nTremors or Coordination Issues: Infrequent but possible in sensitive patients.\n\nBlurred Vision or Double Vision: May occur due to its neurological effects.\n\nWeight Gain or Increased Appetite: Observed in some long-term users.\n\nMood Changes or Irritability: Rarely, Gabapentin may affect mood or concentration.\n\nPrecautions:\n\nAvoid driving or operating heavy machinery until you know how Gabapentin affects you.\n\nInform your doctor if you have kidney problems, as dosage adjustments may be needed.\n\nAbrupt discontinuation should be avoided; the dose should be gradually reduced under medical supervision.\n\nAlcohol and certain medications (like opioids or sedatives) can increase drowsiness when taken with Gabapentin.\n\nConclusion\n\nGabapentin Tablets 400 mg are a trusted and effective solution for managing neuropathic pain and epileptic seizures. By regulating abnormal nerve signals in the brain and spinal cord, Gabapentin offers significant relief from chronic nerve-related pain, improves sleep, and enhances daily functionality.\n\nIts proven safety profile, versatility in multiple conditions, and long-term tolerability make it one of the most commonly prescribed medications for nerve pain and seizure control worldwide.\n\nWhen used as directed by a healthcare professional, Gabapentin 400 mg not only alleviates pain and discomfort but also helps patients regain comfort, confidence, and control over their lives.", "price": 290.0, "discountamount": 87.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2198, "imageuri": "https://productimages.withfloats.com/actual/69141e09fb4d3eac164c0add.png", "tileimageuri": "https://productimages.withfloats.com/tile/69141e09fb4d3eac164c0add.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-11T08:36:19.985Z", "updatedon": "2026-03-13T06:55:23.646Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gabapentin-tablets-400-mg/2198", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STARGAB 400", "category": "NEUROLOGY RANGE", "tags": [ "Gabapentin Tablets 400 mg", "neuropathic pain", "epileptic seizures", "brain that cause seizures or pain.", "nerve pain and seizure control worldwide" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a2708da3a81d5c6a169f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "description": "STERIS SITAGLIPTIN 50 + METFORMIN 500 \nSitagliptin (50mg) & Metformin HCI (500mg)\nIntroduction to STERIS SITAGLIPTIN 50 + METFORMIN 500\nSTERIS SITAGLIPTIN 50 + METFORMIN 500 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, this medication offers comprehensive glycemic control, helping patients effectively manage their blood sugar levels.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. Metformin is a cornerstone in the management of type 2 diabetes due to its effectiveness and safety profile.\n\nBenefits of STERIS SITAGLIPTIN 50 + METFORMIN 500\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: STERIS SITAGLIPTIN 50 + METFORMIN 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use STERIS SITAGLIPTIN 50 + METFORMIN 500\nDosage and Administration\nRecommended Dosage: The typical dosage is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take the medication regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/steris-sitagliptin-50-metformin-500-134361", "price": 285.0, "discountamount": 85.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "liver", "Order", "EMAIL", "meals", "water", "amount", "Action", "option", "Support", "ability", "readings", "Low Risk", "Overview", "biguanide", "neuropathy", "one tablet", "overweight", "full glass", "Guidelines", "information", "Optimal Use", "utilization", "cornerstone", "retinopathy", "Adjustments", "Introduction", "Postprandial", "Reduced Risk", "best results", "sterisonline", "instructions", "DPP-4 enzyme", "Hypoglycemia", "sterispharma", "Metformin HCI", "effectiveness", "CALL/WHATSAPP", "Dual Mechanism", "Administration", "typical dosage", "obese patients", "Consistent Use", "treatment plan", "safety profile", "insulin release", "glucagon levels", "DPP-4) inhibitor", "significant role", "Sitagliptin 50mg", "Exercise Adjunct", "excellent adjunct", "incretin hormones", "weight neutrality", "Weight Management", "prolonged activity", "glucose metabolism", "STERIS SITAGLIPTIN", "Recommended Dosage", "modest weight loss", "blood sugar control", "insulin sensitivity", "Diabetes Management", "healthcare provider", "individual response", "combination medication", "cardiovascular disease", "dipeptidyl peptidase-4", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "Metformin Hydrochloride", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1468, "imageuri": "https://productimages.withfloats.com/actual/6661a271487c46164ce5354d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a271487c46164ce5354d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T11:50:08.381Z", "updatedon": "2026-03-13T09:50:27.092Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//steris-sitagliptin-50-metformin-500-/1468", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "category": "DIABETIC RANGE", "tags": [ "STERIS SITAGLIPTIN 50", "METFORMIN 500", "Sitagliptin (50mg)", "Metformin HCI (500mg)", "Metformin HCl", "Metformin side effects", "Metformin hydrochloride tablet uses", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661967ed91d281c30c75747", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ST-GLIPTIN M 50/500 ", "description": "ST-GLIPTIN M 50/500 \nSitagliptin (50mg), Metformin SR 500\nIntroduction to ST-GLIPTIN M 50/500\nST-GLIPTIN M 50/500 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride Sustained Release (SR) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, ST-GLIPTIN M 50/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of ST-GLIPTIN M 50/500\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ST-GLIPTIN M 50/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, ST-GLIPTIN M 50/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use ST-GLIPTIN M 50/500\nDosage and Administration\nRecommended Dosage: The typical dosage of ST-GLIPTIN M 50/500 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ST-GLIPTIN M 50/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/st-gliptin-m-50-500-134013", "price": 414.9, "discountamount": 124.47, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "meals", "water", "liver", "Action", "amount", "option", "ability", "Support", "Overview", "Low Risk", "readings", "biguanide", "one tablet", "neuropathy", "Guidelines", "full glass", "overweight", "utilization", "Adjustments", "Optimal Use", "information", "Sitagliptin", "retinopathy", "instructions", "Introduction", "Metformin SR", "Postprandial", "sterispharma", "Reduced Risk", "best results", "Hypoglycemia", "sterisonline", "DPP-4 enzyme", "effectiveness", "CALL/WHATSAPP", "Consistent Use", "Dual Mechanism", "obese patients", "typical dosage", "Administration", "treatment plan", "glucagon levels", "insulin release", "DPP-4) inhibitor", "prolonged effect", "significant role", "Exercise Adjunct", "excellent adjunct", "incretin hormones", "weight neutrality", "Weight Management", "prolonged activity", "Recommended Dosage", "modest weight loss", "glucose metabolism", "Diabetes Management", "healthcare provider", "individual response", "insulin sensitivity", "blood sugar control", "ST-GLIPTIN M 50/500", "cardiovascular disease", "combination medication", "dipeptidyl peptidase-4", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "hepatic glucose production", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1457, "imageuri": "https://productimages.withfloats.com/actual/666196810c19ea48b9489473.png", "tileimageuri": "https://productimages.withfloats.com/tile/666196810c19ea48b9489473.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:59:10.485Z", "updatedon": "2026-03-13T06:53:47.01Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//st-gliptin-m-50-500-/1457", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN M 50/500 ", "category": "DIABETIC RANGE", "tags": [ "ST-GLIPTIN M 50/500", "Sitagliptin (50mg)", "Metformin SR 500", "Metformin sr 500 side effects", "Metformin SR 500 uses", "", "Metformin SR 500 price", "Glycomet SR 500 weight loss" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666195738da3a81d5c6a12e7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ST-GLIPTIN M50/1000 ", "description": "ST-GLIPTIN M50/1000 \nSitagliptin (50mg), Metformin SR 1000\nIntroduction to ST-GLIPTIN M50/1000\nST-GLIPTIN M50/1000 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride Sustained Release (SR) 1000mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, ST-GLIPTIN M50/1000 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of ST-GLIPTIN M50/1000\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ST-GLIPTIN M50/1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, ST-GLIPTIN M50/1000 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use ST-GLIPTIN M50/1000\nDosage and Administration\nRecommended Dosage: The typical dosage of ST-GLIPTIN M50/1000 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ST-GLIPTIN M50/1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/st-gliptin-m50-1000-134014", "price": 570.0, "discountamount": 171.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "meals", "water", "liver", "Action", "amount", "option", "ability", "Support", "Overview", "Low Risk", "readings", "biguanide", "one tablet", "full glass", "overweight", "neuropathy", "Guidelines", "Sitagliptin", "information", "retinopathy", "utilization", "Adjustments", "Optimal Use", "instructions", "Hypoglycemia", "Introduction", "Metformin SR", "Postprandial", "sterispharma", "Reduced Risk", "best results", "sterisonline", "DPP-4 enzyme", "CALL/WHATSAPP", "effectiveness", "obese patients", "treatment plan", "Administration", "Dual Mechanism", "typical dosage", "Consistent Use", "glucagon levels", "insulin release", "prolonged effect", "significant role", "Exercise Adjunct", "DPP-4) inhibitor", "weight neutrality", "excellent adjunct", "Weight Management", "incretin hormones", "glucose metabolism", "modest weight loss", "Recommended Dosage", "prolonged activity", "healthcare provider", "ST-GLIPTIN M50/1000", "insulin sensitivity", "blood sugar control", "Diabetes Management", "individual response", "combination medication", "cardiovascular disease", "dipeptidyl peptidase-4", "lifestyle modifications", "Fasting Glucose Control", "long-term complications", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "hepatic glucose production", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1456, "imageuri": "https://productimages.withfloats.com/actual/66619576c06ee12d88d00a83.png", "tileimageuri": "https://productimages.withfloats.com/tile/66619576c06ee12d88d00a83.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:54:43.645Z", "updatedon": "2026-03-13T06:53:11.53Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//st-gliptin-m50-1000-/1456", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN M50/1000 ", "category": "DIABETIC RANGE", "tags": [ "ST-GLIPTIN M50/1000", "Sitagliptin (50mg)", "Metformin SR 1000", "Sitagliptin 50 mg dose", "Sitagliptin side effects", "Sitagliptin 50 mg price", "Sitagliptin 50 mg generic" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66619373ccd5ce1a10759768", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin and metformin hydrochloride tablets", "description": "ST-GLIPTIN 100 \nSitagliptin (100mg)\nIntroduction to ST-GLIPTIN 100\nST-GLIPTIN 100 contains Sitagliptin 100mg, a medication primarily used for the management of type 2 diabetes mellitus. Sitagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help control blood sugar levels by enhancing the body’s own ability to regulate insulin after meals. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Sitagliptin?\nOverview of Sitagliptin\nSitagliptin is an oral diabetes medication that helps increase insulin production and decrease glucose production in the liver. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones. These hormones play a significant role in regulating glucose metabolism.\n\nMechanism of Action\nIncretin Hormones: Sitagliptin enhances the levels of incretin hormones, which increase insulin synthesis and release from pancreatic beta cells in response to meals.\nGlucose Regulation: It reduces the liver’s production of glucose, especially after meals, thereby helping to lower blood sugar levels.\nReduced Blood Sugar Spikes: By increasing insulin release and decreasing glucagon levels, Sitagliptin helps control blood sugar spikes after meals.\nBenefits of ST-GLIPTIN 100\nEffective Blood Sugar Management\nPostprandial Glucose Control: ST-GLIPTIN 100 helps manage postprandial (after-meal) blood sugar levels by enhancing the body’s natural response to meals.\nFasting Blood Sugar Control: It also helps in lowering fasting blood sugar levels, providing a balanced glycemic control throughout the day.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ST-GLIPTIN 100 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nCombination Therapy: It can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin for enhanced glycemic control.\nAdditional Health Benefits\nWeight Neutral: Sitagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nLow Risk of Hypoglycemia: When used alone, sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use ST-GLIPTIN 100\nDosage and Administration\nRecommended Dosage: The typical dosage of ST-GLIPTIN 100 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ST-GLIPTIN 100 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "diet", "food", "body", "meals", "water", "liver", "drugs", "EMAIL", "Order", "class", "adults", "option", "Action", "ability", "Support", "Low Risk", "readings", "Overview", "patients", "same time", "Mechanism", "metformin", "full glass", "one tablet", "ST-GLIPTIN", "Guidelines", "Optimal Use", "weight gain", "Adjustments", "information", "sterisonline", "DPP-4 enzyme", "Introduction", "best results", "Hypoglycemia", "sterispharma", "sulfonylureas", "CALL/WHATSAPP", "typical dosage", "Administration", "Consistent Use", "treatment plan", "Weight Neutral", "insulin release", "glucagon levels", "Exercise Adjunct", "natural response", "significant role", "Sitagliptin 100mg", "insulin synthesis", "incretin hormones", "excellent adjunct", "Recommended Dosage", "glucose production", "insulin production", "prolonged activity", "Glucose Regulation", "glucose metabolism", "Blood Sugar Control", "Diabetes Management", "healthcare provider", "individual response", "Combination Therapy", "pancreatic beta cells", "lifestyle modifications", "meal) blood sugar levels", "oral diabetes medication", "type 2 diabetes mellitus", "balanced glycemic control", "enhanced glycemic control", "other diabetes medications", "Additional Health Benefits", "Reduced Blood Sugar Spikes", "Postprandial Glucose Control", "other antidiabetic medications", "Effective Blood Sugar Management", "dipeptidyl peptidase-4 (DPP-4) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1454, "imageuri": "https://productimages.withfloats.com/actual/66619377e874b19df8bb10f6.png", "tileimageuri": "https://productimages.withfloats.com/tile/66619377e874b19df8bb10f6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:46:11.53Z", "updatedon": "2026-01-24T07:31:15.432Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-and-metformin-hydrochloride-tablets/1454", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN 100 ", "category": "DIABETIC RANGE", "tags": [ "ST-GLIPTIN 100", "Sitagliptin (100mg)", "Sitagliptin 100mg side effects", "Sitagliptin 100 mg price", "Sitagliptin 100 mg brands in India", "", "Sitagliptin 100 mg dose", "Sitagliptin 50" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66619278db9fdd21801ef284", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " Glimepiride, Metformin SR Sustained Release, and Voglibose", "description": "SEIZMET TRIO 0.3 \nGlimepiride (2mg), Metformin SR (500mg), Voglibose (0.3mg)\nIntroduction to SEIZMET TRIO 0.3\nSEIZMET TRIO 0.3 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Voglibose 0.3mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Voglibose, SEIZMET TRIO 0.3 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Voglibose?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Voglibose\nVoglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by slowing the digestion and absorption of carbohydrates in the small intestine. This leads to a slower and lower rise in blood glucose levels after meals.\n\nBenefits of SEIZMET TRIO 0.3\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Voglibose slows carbohydrate absorption. This comprehensive approach offers robust glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET TRIO 0.3 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET TRIO 0.3 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nImproved Glycemic Control: Voglibose’s action on slowing carbohydrate absorption leads to better control over postprandial spikes, contributing to overall glycemic stability.\nHow to Use SEIZMET TRIO 0.3\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET TRIO 0.3 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Voglibose. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET TRIO 0.3 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now", "price": 156.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "3", "day", "body", "Diet", "EMAIL", "Order", "liver", "water", "meals", "amount", "slower", "option", "Action", "Support", "Overview", "pancreas", "readings", "digestion", "biguanide", "Voglibose", "one tablet", "lower rise", "overweight", "Guidelines", "full glass", "neuropathy", "utilization", "Adjustments", "information", "retinopathy", "Optimal Use", "Introduction", "Metformin SR", "SEIZMET TRIO", "best results", "sterisonline", "Reduced Risk", "instructions", "sterispharma", "sulfonylurea", "effectiveness", "CALL/WHATSAPP", "carbohydrates", "Administration", "obese patients", "typical dosage", "treatment plan", "Consistent Use", "Glimepiride 2mg", "small intestine", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "excellent adjunct", "Weight Management", "weight neutrality", "insulin secretion", "Recommended Dosage", "modest weight loss", "blood sugar control", "Diabetes Management", "individual response", "postprandial spikes", "healthcare provider", "insulin sensitivity", "blood glucose levels", "pancreatic beta cells", "cardiovascular disease", "combination medication", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "robust glycemic control", "lifestyle modifications", "carbohydrate absorption", "type 2 diabetes mellitus", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "overall glycemic stability", "alpha-glucosidase inhibitor", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1453, "imageuri": "https://productimages.withfloats.com/actual/6661927b487c46164ce4b1f6.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661927b487c46164ce4b1f6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:42:00.595Z", "updatedon": "2026-03-13T06:32:38.939Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//-glimepiride-metformin-sr-sustained-release-and-voglibose/1453", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET TRIO 0.3 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET TRIO 0.3", "Glimepiride (2mg)", "Metformin SR (500mg)", "Voglibose (0.3mg)", "Glimepiride 2mg side effects", "glimepiride + metformin", "Glimepiride 2mg price", "Glimepiride 2mg Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666191664515df1748621e0b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride 2mg, Metformin SR 500mg, Voglibose 0.2mg", "description": "SEIZMET TRIO 0.2 \nGlimepiride (2mg), Metformin SR (500mg), Voglibose (0.2mg)\nIntroduction to SEIZMET TRIO 0.2\nSEIZMET TRIO 0.2 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Voglibose 0.2mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Voglibose, SEIZMET TRIO 0.2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Voglibose?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Voglibose\nVoglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by slowing the digestion and absorption of carbohydrates in the small intestine. This leads to a slower and lower rise in blood glucose levels after meals.\n\nBenefits of SEIZMET TRIO 0.2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Voglibose slows carbohydrate absorption. This comprehensive approach offers robust glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET TRIO 0.2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET TRIO 0.2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nImproved Glycemic Control: Voglibose’s action on slowing carbohydrate absorption leads to better control over postprandial spikes, contributing to overall glycemic stability.\nHow to Use SEIZMET TRIO 0.2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET TRIO 0.2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Voglibose. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET TRIO 0.2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-trio-0-2-133445", "price": 155.9, "discountamount": 46.77, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Diet", "body", "liver", "meals", "water", "Order", "EMAIL", "option", "amount", "slower", "Action", "Support", "readings", "Overview", "pancreas", "Improved", "Voglibose", "digestion", "biguanide", "neuropathy", "full glass", "lower rise", "overweight", "one tablet", "Guidelines", "information", "Adjustments", "retinopathy", "utilization", "Optimal Use", "Metformin SR", "best results", "Introduction", "SEIZMET TRIO", "sterisonline", "Reduced Risk", "instructions", "sterispharma", "sulfonylurea", "effectiveness", "CALL/WHATSAPP", "carbohydrates", "Administration", "obese patients", "typical dosage", "treatment plan", "Consistent Use", "Glimepiride 2mg", "small intestine", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "excellent adjunct", "Weight Management", "weight neutrality", "insulin secretion", "Recommended Dosage", "modest weight loss", "blood sugar control", "Diabetes Management", "individual response", "postprandial spikes", "healthcare provider", "insulin sensitivity", "blood glucose levels", "pancreatic beta cells", "cardiovascular disease", "combination medication", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "robust glycemic control", "lifestyle modifications", "carbohydrate absorption", "type 2 diabetes mellitus", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "overall glycemic stability", "alpha-glucosidase inhibitor", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1452, "imageuri": "https://productimages.withfloats.com/actual/6661916a8e77bb2c7156e563.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661916a8e77bb2c7156e563.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:37:26.597Z", "updatedon": "2026-03-13T06:31:35.361Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-2mg-metformin-sr-500mg-voglibose-0-2mg/1452", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET TRIO 0.2 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET TRIO 0.2", "Glimepiride (2mg)", "Metformin SR (500mg)", "Voglibose (0.2mg)", "Glimepiride 2mg side effects", "glimepiride + metformin", "Glimepiride 2mg price", "Glimepiride 2mg Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }